Résumé
The collagenous, extracellular matrix (ECM) forms a stress-tolerant network that is essential for proper function of the vertebrate heart. Profound changes have been detected in the interstitial ECM concurrent with developmental and disease processes of the heart. These alterations in either the organization or accumulation of ECM components markedly affect myocardial function. Studies have shown that a number of biochemical factors, including angiotensin II, transforming growth factor-β, and insulin-like growth factors, modulate collagen expression by heart fibroblasts, however, few studies have examined the differential effects of these factors on fibroblasts from animals of different physiological backgrounds. The present studies were carried out to determine whether cardiac fibroblasts isolated from different aged animals (fetal, neonatal, and adult) have diverse responses to insulin-like growth factor-1 (IGF-1). Fibroblasts isolated from fetal, neonatal, and adult rat hearts were treated with IGF-1, and several down-stream responses were measured, including collagen gel contraction, adhesion to ECM, and expression of interstitial collagen and integrins. IGF-1 affected these parameters to different degrees, depending on the age of the animal from which the fibroblasts were isolated. These experiments indicate that IGF-1 is a potent modulator of fibroblast behavior in general; however, significant differences are apparent in the responsiveness of cells to this growth factor depending on the age of the animal of origin. Future experiments will be directed at determining how the in vivo chemical and biomechanical environment affects the response of heart fibroblasts to growth factors such as IGF-1.
Langue d'origine | English |
---|---|
Pages (de-à) | 155-165 |
Nombre de pages | 11 |
Journal | Cell Communication and Adhesion |
Volume | 10 |
Numéro de publication | 3 |
DOI | |
Statut de publication | Published - 2003 |
Financement
The authors would like to thank Cheryl Cook and Adam Carver for their valuable assistance with the described experiments. This work was supported by NIH grant # HL62228 and FONDECYT Grant # 1020587.
Bailleurs de fonds | Numéro du bailleur de fonds |
---|---|
National Institutes of Health | |
National Heart, Lung, and Blood Institute | R01HL062228 |
Fondo Nacional de Desarrollo Científico, Tecnológico y de Innovación Tecnológica | 1020587 |
ASJC Scopus Subject Areas
- Clinical Biochemistry
- Cell Biology